Eisenberg R A, Pisetsky D S, Craven S Y, Grudier J P, O'Donnell M A, Cohen P L
Department of Medicine, University of North Carolina, Chapel Hill 27599.
J Clin Invest. 1990 Jan;85(1):86-92. doi: 10.1172/JCI114437.
The administration of certain monoclonal anti-Sm antibodies (2G7, 7.13) induced most MRL/lpr mice to become anti-Sm positive by 5 mo of age, although other anti-Sm monoclonals (Y2, Y12) suppressed the spontaneous response. Positive anti-Sm antibody enhancement occurred efficiently only in MRL/lpr mice and not in other systemic lupus erythematosus mice that have little spontaneous anti-Sm production. The enhancement by anti-Sm antibodies was specific for the anti-Sm response. The mechanism of the passive antibody enhancement was apparently not isotype- or idiotype-related. The fine specificity of the anti-Sm monoclonal antibody may be essential to its enhancing or suppressing effects, since both enhancing monoclonals recognized only the D Sm polypeptide, whereas both suppressing monoclonals saw the D and the B polypeptides. Furthermore, analysis of serial bleeds from unmanipulated MRL mice that developed anti-Sm positivity showed that the D specificity almost always appeared first. We hypothesize, therefore, that those animals in which an anti-Sm response is initiated by D-specific B-cell clones can become serologically positive with the aid of a positive feedback loop. In contrast, animals in which the initial specificity is for both B and D peptides would be prevented from developing a full anti-Sm response.
某些抗Sm单克隆抗体(2G7、7.13)的给药可使大多数MRL/lpr小鼠在5月龄时抗Sm呈阳性,尽管其他抗Sm单克隆抗体(Y2、Y12)可抑制自发反应。抗Sm抗体阳性增强仅在MRL/lpr小鼠中有效发生,而在其他几乎没有自发抗Sm产生的系统性红斑狼疮小鼠中则不会发生。抗Sm抗体的增强作用对抗Sm反应具有特异性。被动抗体增强的机制显然与同种型或独特型无关。抗Sm单克隆抗体的精细特异性可能对其增强或抑制作用至关重要,因为两种增强性单克隆抗体仅识别D Sm多肽,而两种抑制性单克隆抗体则识别D和B多肽。此外,对自发出现抗Sm阳性的未处理MRL小鼠的系列出血进行分析表明,D特异性几乎总是首先出现。因此,我们推测,那些由D特异性B细胞克隆引发抗Sm反应的动物可借助正反馈回路在血清学上呈阳性。相比之下,初始特异性针对B和D肽的动物将无法产生完全的抗Sm反应。